300558.SZ
贝达药业
SZSE · Healthcare · C 制造业 · CN
CNY 48.53
−5.18%Margins
Gross margin
79.0%
EBITDA margin
25.9%
EBIT margin
15.5%
Net margin
11.8%
FCF margin
2.7%
6.5%
Return on equity
4.1%
Return on assets
6.8%
Return on invested capital
0.35x
Asset turnover
CNY 877.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026